Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between Equol Production Status and Nonalcoholic Steatohepatitis.
Akahane T, Kaya D, Noguchi R, Kaji K, Miyakawa H, Fujinaga Y, Tsuji Y, Takaya H, Sawada Y, Furukawa M, Kitagawa K, Ozutsumi T, Kawaratani H, Moriya K, Namisaki T, Yoshiji H. Akahane T, et al. Among authors: noguchi r. Int J Mol Sci. 2021 Nov 2;22(21):11904. doi: 10.3390/ijms222111904. Int J Mol Sci. 2021. PMID: 34769332 Free PMC article.
Impact of insulin resistance on the progression of chronic liver diseases.
Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Yoshii J, Yanase K, Namisaki T, Yamazaki M, Moriya K, Tsujimoto T, Kawaratani H, Akahane T, Uemura M, Fukui H. Kaji K, et al. Among authors: noguchi r. Int J Mol Med. 2008 Dec;22(6):801-8. Int J Mol Med. 2008. PMID: 19020779
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.
Douhara A, Moriya K, Yoshiji H, Noguchi R, Namisaki T, Kitade M, Kaji K, Aihara Y, Nishimura N, Takeda K, Okura Y, Kawaratani H, Fukui H. Douhara A, et al. Among authors: noguchi r. Mol Med Rep. 2015 Mar;11(3):1693-700. doi: 10.3892/mmr.2014.2995. Epub 2014 Nov 24. Mol Med Rep. 2015. PMID: 25421042 Free PMC article.
Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.
Namisaki T, Noguchi R, Moriya K, Kitade M, Aihara Y, Douhara A, Nishimura N, Takeda K, Okura Y, Kawaratani H, Takaya H, Seki K, Yoshiji H. Namisaki T, et al. Among authors: noguchi r. J Gastroenterol. 2016 Feb;51(2):162-72. doi: 10.1007/s00535-015-1104-x. Epub 2015 Jul 21. J Gastroenterol. 2016. PMID: 26190501
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Ozutsumi T, Namisaki T, Shimozato N, Kaji K, Tsuji Y, Kaya D, Fujinaga Y, Furukawa M, Nakanishi K, Sato S, Sawada Y, Saikawa S, Kitagawa K, Takaya H, Kawaratani H, Kitade M, Moriya K, Noguchi R, Akahane T, Mitoro A, Yoshiji H. Ozutsumi T, et al. Among authors: noguchi r. Int J Mol Sci. 2020 Mar 21;21(6):2164. doi: 10.3390/ijms21062164. Int J Mol Sci. 2020. PMID: 32245205 Free PMC article.
Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats.
Noguchi R, Kaji K, Namisaki T, Moriya K, Kawaratani H, Kitade M, Takaya H, Aihara Y, Douhara A, Asada K, Nishimura N, Miyata T, Yoshiji H. Noguchi R, et al. Mol Med Rep. 2020 Oct;22(4):2948-2956. doi: 10.3892/mmr.2020.11360. Epub 2020 Jul 28. Mol Med Rep. 2020. PMID: 32945412 Free PMC article.
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.
Fujinaga Y, Namisaki T, Tsuji Y, Suzuki J, Murata K, Takeda S, Takaya H, Inoue T, Noguchi R, Fujimoto Y, Enomoto M, Nishimura N, Kitagawa K, Kaji K, Kawaratani H, Akahane T, Mitoro A, Yoshiji H. Fujinaga Y, et al. Among authors: noguchi r. Int J Mol Sci. 2022 Aug 29;23(17):9814. doi: 10.3390/ijms23179814. Int J Mol Sci. 2022. PMID: 36077228 Free PMC article.
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Shirai Y, Aihara Y, Namisaki T, Yoshii J, Yanase K, Tsujimoto T, Kawaratani H, Fukui H. Kaji K, et al. Among authors: noguchi r. Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G1094-104. doi: 10.1152/ajpgi.00365.2010. Epub 2011 Mar 3. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21372165 Free article.
348 results